Your session is about to expire
← Back to Search
Cancer-Detecting Dye for Oral Cancer
Study Summary
This trial is testing a new cancer-detecting dye to see if it is safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 3 trial • 154 Patients • NCT02184195Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am fully active or can carry out light work.My cancer is at any stage but has not spread to distant organs.I am 18 years old or older.I am currently taking or have taken a PARP1 inhibitor.My cancer is a type of squamous cell carcinoma located in my mouth or throat.I haven't had surgery in my mouth or throat area in the last 2 weeks.I am scheduled for surgery at MSK.
- Group 1: Fluorescent PARPi Binding Imaging Agent PARPi-FL
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for potential participants in this experiment?
"This clinical trial is still accepting patients; the listing was posted on March 15th 2017 and its most recent update occured June 3rd of this year."
Is this clinical trial a pioneering endeavor?
"Olaparib has seen 188 active medical trials in 1468 cities and 59 nations since its Phase 1 trial by AstraZeneca began in 2005. Since then, 63 further investigations have been concluded."
What medical conditions may Olaparib be utilized to address?
"Olaparib is usually prescribed for cases of advanced illness. It has also been seen to alleviate malignant neoplasm of ovary, primary peritoneal cancer, and somatic hallucinations."
Are there any historical reports of Olaparib being tested in clinical trials?
"Currently, 188 medical trials are investigating olaparib. 27 of those experiments have moved on to the third stage of testing and Houston is home to the majority; though there are 9250 areas that host studies about this medication."
How many participants are included in this trial's scope?
"Affirmative. According to information presented on clinicaltrials.gov, this research project is actively seeking volunteers and has been since the 15th of March 2017. Most recently updated on June 3rd 2022, it needs 39 individuals from one medical centre for participation."
Share this study with friends
Copy Link
Messenger